New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome


You May Also Like

VBL Therapeutics Announces Year End 2017 Financial Results

Conference Call and Webcast at 8:30am Eastern Time TEL AVIV, Israel, March 15, 2018 ...

Sunesis Announces Pricing of $20 Million Offering of Securities

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...